home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177
ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177
Post navigation
Previous Post
Previous
Boundless Bio Appoints Jami Rubin as Chief Financial Officer
Next Post
Next
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital